DxTerity
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
19500 S Rancho Way Ste 116, East Rancho ...Phone Number
(310) 537-7857Website
www.dxterity.comRevenue
$12.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About DxTerity
DxTerity is a pioneering company specializing in RNA-based diagnostics for autoimmune diseases, providing precision testing that empowers patients to manage their health. Their innovative approach focuses on understanding the biological underpinnings of autoimmune conditions, offering healthcare providers more precise tools for diagnosis and treatment. Committed to affordability, DxTerity utilizes patented technologies to deliver cutting-edge precision medicine at a low cost. The company aims to enhance patient well-being through at-home genomic monitoring and is actively involved in clinical studies to advance the understanding and treatment of autoimmune diseases.Explore more
DxTerity Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DxTerity your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if DxTerity is spiking on competitors!
DxTerity, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on DxTerity recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when DxTerity launches new products
Funding: Get notified immidiatlly once DxTerity has new funding data
Click to see if DxTerity had a recent Job posting/layoffs
Check if DxTerity has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at DxTerity
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to DxTerity
Compare insights from companies similar to DxTerity, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
DxTerity is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DxTerity is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DxTerity.
DxTerity financials insights
Gather financial insights about DxTerity, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Private Equity
$790K
2012
Debt
$2.6M
2020
Debt
$350K
2021
Debt
$794K
DxTerity Tech Stack
A closer look at the technologies used by DxTerity
Most Recent Scoops
Event
Events, Laboratory Operations, Medical Research, Pharmaceuticals, Public Health, Clinical Operations
Funding
DxTerity has received an SBA PPP loan in the amount of $794,660 from Silicon Valley Bank resulting in the retention of 50 jobs.
Funding
DxTerity has received an SBA PPP loan for $350,000-1 million from Silicon Valley Bank, supporting the retention of 32 jobs.
New Hire
Executive Move
Brett Swansiger has been appointed to the role of Senior VP & Chief Commercial Officer (Managed Care). In this role, Swansiger is responsible for strategic business partnerships. Previously, Swansiger served as Senior VP, US Sales & Integrated Healthcare Systems at MDxHealth.
Executive Moves, New Hire
Funding
Funding
DxTerity News & Media
DxTerity Diagnostics Announces the Launch of IFN-1 Test for Lupus
New test aims to identify patients that may benefit from precision treatment LOS ANGELES, June 9, 2022 /PRNewswire/ -- DxTerity Diagnostics today announced the commercial launch of their IFN-1 Test for patients with Systemic Lupus Erythematosus (SLE or lupus). The IFN-1 Test supports the...DxTerity Diagnostics Begins Enrollment in the ELEVATE Clinical Study for Lupus
ELEVATE aims to identify biomarkers for the advancement of SLE precision medicine LOS ANGELES, May 27, 2022 /PRNewswire/ -- DxTerity Diagnostics today announced the opening of enrollment in ELEVATE (Empower Lupus Erythematous Patients Via Allowing RemoTe Evaluation), a new observational...DxTerity Diagnostics Announces "A Safe and Joyful 2022 Program" for Its PCR-Based Covid-19 Test
LOS ANGELES, Dec. 23, 2021 /PRNewswire/ -- In response to President Biden's urging that Americans go forward with their holiday plans, DxTerity Diagnostics announced today, it is offering a 20% off on its saliva-based at-home PCR Covid-19 test until January 10, 2022, through Amazon.com....DxTerity Diagnostics Announces its OSHA Emergency Temporary Standard (ETS) Compliance-Ready COVID-19 Employer Screening Service
LOS ANGELES, Nov. 8, 2021 /PRNewswire/ -- DxTerity Diagnostics announced today its SafeWorkDx™ subscription service meets all of OSHA's latest guidelines outlined within the November 5th published ETS and is available now for employers looking for comprehensive COVID-19 testing and...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DxTerity
Sign Up For FreeTo access detailed company insights
DxTerity is a pioneering company specializing in RNA-based diagnostics for autoimmune diseases, providing precision testing that empowers patients to manage their health. Their innovative approach focuses on understanding the biological underpinnings of autoimmune conditions, offering healthcare providers more precise tools for diagnosis and treatm... Read More
